Research-Grade Adalimumab Overview
Humira Pre-Filled Pen is a pharmaceutical-grade adalimumab preparation manufactured by Abbott Pharma for laboratory research applications. Adalimumab is a recombinant human immunoglobulin G1 (IgG1) monoclonal antibody that binds specifically to tumour necrosis factor alpha (TNF-α). This prefilled delivery system provides consistent dosing accuracy for research protocols examining TNF-α pathway inhibition. The monoclonal antibody demonstrates high binding affinity for soluble and membrane-bound TNF-α, effectively neutralising biological activity through immune complex formation. Researchers at Stroid UK Shop utilise this pharmaceutical preparation to investigate inflammatory signalling pathways and cytokine network interactions in controlled laboratory environments.
Laboratory Research Applications
Adalimumab serves as a critical tool in immunological research for studying TNF-α mediated inflammatory responses. Research teams examine its effects on cytokine cascades, particularly in models of autoimmune disease progression and inflammatory bowel conditions. The compound’s mechanism involves competitive binding to TNF-α receptors, preventing natural ligand interaction and downstream inflammatory signalling. Studies evaluate adalimumab’s impact on nuclear factor kappa B (NF-κB) pathway modulation and interleukin production in cell culture systems. Researchers investigating therapeutic antibody development often compare adalimumab against novel compounds in their general health research programmes. The prefilled pen format ensures precise dosing for concentration-response experiments and bioavailability studies. Academic institutions examine adalimumab’s pharmacokinetic properties alongside other biological compounds, including selective androgen receptor modulators and research peptides for comprehensive therapeutic development programmes.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Adalimumab |
| Manufacturer | Abbott Pharma |
| Delivery Format | Pre-filled pen injection |
| Product Code | EU1814 |
| Molecular Target | TNF-alpha |
| Antibody Class | IgG1 monoclonal |
| Storage Requirements | 2-8°C refrigeration |
| Research Use | In-vitro laboratory only |
Research Compliance Statement
Humira Pre-Filled Pen adalimumab is supplied exclusively for in-vitro research applications by qualified laboratory personnel. This pharmaceutical preparation is not intended for human consumption, clinical treatment, or diagnostic purposes. Research institutions must maintain appropriate biosafety protocols when handling monoclonal antibody preparations and ensure proper disposal of biological waste materials. All experimental procedures should comply with institutional review board guidelines and Good Laboratory Practice standards. Storage requires continuous refrigeration between 2-8°C to maintain protein stability and biological activity. Researchers must verify compatibility with their specific research protocols and obtain necessary ethical approvals before commencing experimental work involving this pharmaceutical material.
